Aicardi-Goutières syndrome (AGS) is a brain condition characterized by type I interferon (IFN)-mediated inflammation. Here, the authors demonstrate a negative correlation between the metabolic regulator, HIF-1α, and type-I IFN responses in AGS.
- Maxime Batignes
- Marine Luka
- Mickaël M. Ménager